semaglutide supply shortage news november 2025 The Is Ending: What's Next For Compounded Drugs? The Wegovy Shortage Continues, Leaving

The Big Picture: This milestone opens a new chapter for upstream raw material suppliers and formulation technologists

We reduce friction and time to purchase by making the first tool to compare providers who are licensed in your state with transparent pricing

The FDA has sent a warning letter to the makers of Ozempic over unreported side effects.

Access with structure

In most major obesity trials, GLP-1 therapy was: Escalated to high or maximum tolerated doses Stopped abruptly, not down-titrated Followed by little or no continuation of structured lifestyle support In the STEP-1 extension trial (semaglutide 2.4 mg), participants who discontinued therapy regained approximately two-thirds of their prior weight loss over the following year

Discover medical-grade GLP-1 weight loss support starting at $135/mo